GO:1990140 molybdopterin synthase complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990140 defines the molybdopterin synthase complex, a heterotetrameric enzyme that catalyzes the final sulfur-transfer step in molybdopterin (MPT) biosynthesis.
• In E. coli the complex comprises MoaE and MoaD subunits; in humans the orthologous subunits are MOCS2B and MOCS2A.
• The catalytic mechanism involves formation of a thiocarboxylate on the small subunit (MoaD/MOCS2A), followed by sulfur transfer to precursor Z to yield molybdopterin.
• The complex is evolutionarily conserved and its dysfunction is linked to molybdenum cofactor (Moco) deficiency, a severe metabolic disorder.
• Beyond Moco biosynthesis, MoaE and MOCS2 have been reported to have moonlighting roles in other cellular processes.
• Studying this complex requires integrated structural, biochemical, and CRISPR-based approaches to dissect subunit interactions and disease variants.
Description
The molybdopterin synthase complex (GO:1990140) is a heterotetrameric protein complex that catalyzes the sulfur transfer from the sulfur carrier subunit to precursor Z, forming molybdopterin (MPT) as part of molybdenum cofactor (Moco) biosynthesis. Moco is an essential cofactor for enzymes involved in redox reactions, including sulfite oxidase, xanthine dehydrogenase, and aldehyde oxidase. The complex is highly conserved across evolution, with subunits MoaE and MoaD in Escherichia coli and MOCS2B and MOCS2A in humans. Researchers study GO:1990140 to understand the final step of MPT biosynthesis, which is critical for Moco-dependent metabolic pathways. Structural and mechanistic studies have revealed that the complex undergoes dynamic subunit interactions and a unique sulfur-transfer mechanism involving a thiocarboxylate intermediate. Mutations in the human genes encoding these subunits cause molybdenum cofactor deficiency, a rare but devastating disorder characterized by severe neurological symptoms. Recent work has expanded the functional landscape of this complex, revealing moonlighting roles for its subunits in processes such as alkylation damage signaling and sterol biosynthesis. These findings underscore the importance of GO:1990140 beyond its canonical biosynthetic function and highlight the need for advanced research tools to dissect its roles in health and disease.
molybdopterin synthase complex At A Glance
| GO ID | GO:1990140 |
|---|---|
| GO term | molybdopterin synthase complex |
| Ontology | cellular_component |
| Synonym | molybdopterin cofactor (Moco) biosynthesis sulfurtransferase complex; molybdopterin converting factor complex; MPT synthase complex |
| Major function | Catalyzes sulfur transfer from the sulfur carrier subunit to precursor Z to synthesize molybdopterin, a step in Moco biosynthesis |
| Subunit composition | Heterotetramer of two large subunits (MoaE/MOCS2B) and two small subunits (MoaD/MOCS2A) |
| Evolutionary conservation | Conserved from bacteria to humans |
| Cellular location | Cytoplasm (in bacteria and eukaryotes) |
| Related disease | Molybdenum cofactor deficiency |
What Is GO:1990140?
The molybdopterin synthase complex is a heterotetrameric protein assembly that catalyzes the transfer of sulfur from a sulfur carrier subunit to precursor Z, yielding molybdopterin. This reaction is a key step in the biosynthesis of the molybdenum cofactor (Moco). The complex is composed of two large subunits (MoaE in E. coli, MOCS2B in humans) and two small subunits (MoaD in E. coli, MOCS2A in humans). The small subunit is activated by thiocarboxylation at its C-terminus, and the large subunit provides the catalytic environment for sulfur transfer. The complex is evolutionarily conserved and is essential for Moco-dependent enzyme activities.
Why Is molybdopterin synthase complex Important in Cell Biology?
The molybdopterin synthase complex is essential for the biosynthesis of the molybdenum cofactor (Moco), which is required for the activity of several key metabolic enzymes, including sulfite oxidase, xanthine dehydrogenase, and aldehyde oxidase. Without functional Moco, these enzymes are inactive, leading to severe metabolic imbalances. In humans, mutations in MOCS2 (encoding both MOCS2A and MOCS2B) cause molybdenum cofactor deficiency, a rare autosomal recessive disorder characterized by severe neurological damage, seizures, and early death. Understanding the structure, mechanism, and regulation of this complex is therefore critical for developing therapeutic strategies and for basic research in metabolism and enzymology.
• Catalyzes the final step of molybdopterin biosynthesis, a prerequisite for Moco formation.
• Moco is essential for sulfite oxidase, xanthine dehydrogenase, and aldehyde oxidase, linking the complex to sulfur and purine metabolism.
• Mutations in human MOCS2 cause molybdenum cofactor deficiency, a severe neurological disorder.
• The complex is a target for mechanistic studies of sulfur transfer and dithiolene formation.
• Subunit interactions are thermodynamically tuned, providing a model for protein-protein recognition.
• MoaE and MOCS2 have moonlighting roles beyond Moco biosynthesis, including in alkylation damage signaling and sterol biosynthesis.
• The complex is conserved across bacteria, plants, and animals, making it a model for evolutionary biochemistry.
• Structural studies of MoaE from Mycobacterium tuberculosis provide insights into assembly and specificity.
• Proteolytic processing of MoaD-MoaE fusions by JAMM/MPN+ proteases reveals regulatory mechanisms.
• CRISPR-based models can dissect the contribution of individual subunits to complex function and disease.
Core Biology of the molybdopterin synthase complex
What Happens During molybdopterin synthase complex?
In simple terms: The complex acts like a molecular assembly line that adds sulfur to a precursor molecule to build molybdopterin.
The molybdopterin synthase complex catalyzes the transfer of sulfur from the sulfur carrier subunit (MoaD/MOCS2A) to precursor Z, forming molybdopterin. This reaction is the final step in the biosynthesis of molybdopterin, which is then converted to the molybdenum cofactor (Moco). The process begins with the activation of the small subunit by thiocarboxylation at its C-terminal glycine, forming a thiocarboxylate intermediate. The large subunit (MoaE/MOCS2B) then facilitates the transfer of sulfur to precursor Z, resulting in the formation of the dithiolene group of molybdopterin. This step is essential for Moco biosynthesis and is conserved across species.
Structure and Composition of molybdopterin synthase complex
In simple terms: The complex is made of four parts: two large and two small subunits that fit together like a puzzle.
The molybdopterin synthase complex is a heterotetramer composed of two large subunits (MoaE in E. coli, MOCS2B in humans) and two small subunits (MoaD in E. coli, MOCS2A in humans). The large subunit adopts a fold that creates the active site for sulfur transfer, while the small subunit serves as the sulfur carrier. Structural studies of the complex with precursor Z have revealed the architecture of the active site and the mechanism of sulfur transfer. In Mycobacterium tuberculosis, three MoaE proteins have been structurally compared, providing insights into assembly and specificity. The complex is stabilized by extensive subunit interactions, as shown by thermodynamic analysis.
Molecular Mechanism of molybdopterin synthase complex
In simple terms: The small subunit carries sulfur, and the large subunit uses it to modify the precursor, forming the active cofactor.
The catalytic mechanism of the molybdopterin synthase complex involves the formation of a thiocarboxylate on the small subunit (MoaD/MOCS2A) at its C-terminal glycine. This thiocarboxylate is generated by the action of MoeB/MOCS3, a ubiquitin-like activating enzyme. The large subunit (MoaE/MOCS2B) then catalyzes the transfer of sulfur from the thiocarboxylate to precursor Z, forming molybdopterin. Mutational studies have identified key residues in MoaE that are essential for catalysis. The reaction is thought to proceed through a covalent intermediate, and the complex undergoes conformational changes during the catalytic cycle. The mechanism is conserved from bacteria to humans.
Regulation and Moonlighting Roles
In simple terms: The complex is mainly used for cofactor production, but its parts can also have other jobs in the cell.
The expression and activity of the molybdopterin synthase complex are regulated in response to cellular needs for Moco. In E. coli, the moa operon is regulated by molybdenum availability and other factors. In humans, MOCS2 is expressed from a bicistronic transcript, and its expression is subject to translational control. Beyond Moco biosynthesis, MoaE and MOCS2 have been reported to have moonlighting roles. For example, MOCS2 is involved in alkylation damage signaling through the MPTAC complex, which links to sterol biosynthesis. Additionally, MoaE has been implicated in other cellular processes independent of Moco. Proteolytic processing of MoaD-MoaE linear fusions by JAMM/MPN+ domain proteases such as DR0402 in Deinococcus radiodurans suggests additional regulatory layers.
Key Genes Involved in GO:1990140 molybdopterin synthase complex
The following genes and proteins are key components or regulators of the molybdopterin synthase complex and its related pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MoaE (E. coli) | Large subunit of molybdopterin synthase; catalyzes sulfur transfer | Model for mechanistic and structural studies |
| MoaD (E. coli) | Small subunit; sulfur carrier via thiocarboxylate | Studied for thiocarboxylation and sulfur transfer |
| MOCS2B (human) | Large subunit of molybdopterin synthase | Mutations cause Moco deficiency; target for disease modeling |
| MOCS2A (human) | Small subunit; sulfur carrier | Mutations cause Moco deficiency; studied for moonlighting roles |
| MOCS3 (human) | MoeB homolog; activates MOCS2A by thiocarboxylation | Essential for MPT synthase activity; potential drug target |
| MoeB (E. coli) | Activates MoaD by thiocarboxylation | Model for ubiquitin-like activation |
| MoaA (E. coli) | Involved in precursor Z synthesis | Upstream of MPT synthase; part of Moco pathway |
| MoaC (E. coli) | Involved in precursor Z synthesis | Upstream of MPT synthase |
| MoaB (E. coli) | Involved in Moco biosynthesis | Part of the moa operon |
| MOCS1 (human) | Involved in precursor Z synthesis | Mutations cause Moco deficiency type A |
| Gephyrin (human) | Moco biosynthesis enzyme (molybdopterin adenylyltransferase) | Mutations cause Moco deficiency type C |
| MOCS2 (human) | Bicistronic gene encoding MOCS2A and MOCS2B | Mutations cause Moco deficiency type B |
| DR0402 (D. radiodurans) | JAMM/MPN+ protease that cleaves MoaD-MoaE fusion | Regulatory mechanism for MPT synthase |
| MoaE (M. tuberculosis) | Large subunit; structural homolog | Insights into assembly and specificity |
| MPTAC (human) | Complex containing MOCS2; links alkylation damage to sterol biosynthesis | Moonlighting role of MOCS2 |
| SUMO/ubiquitin-like proteins | Analogous to MoaD/MOCS2A in activation | Evolutionary link to ubiquitin-like systems |
How Is molybdopterin synthase complex Regulated?
The molybdopterin synthase complex is regulated at multiple levels. In E. coli, the moa operon is induced under anaerobic conditions and in the presence of molybdate. In humans, MOCS2 expression is controlled by a bicistronic transcript that produces both MOCS2A and MOCS2B, and its translation is subject to regulation. The activity of the complex depends on the thiocarboxylation of MOCS2A by MOCS3, which is an ATP-dependent process. Additionally, proteolytic processing of MoaD-MoaE fusions by JAMM/MPN+ proteases may regulate the availability of active subunits. Moonlighting roles of MOCS2 in alkylation damage signaling suggest that its function is integrated with cellular stress responses.
molybdopterin synthase complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MOCS2 | Molybdenum cofactor deficiency type B | Knockout or point-mutation in human cell lines; patient-derived iPSCs |
| MOCS2 | Alkylation damage signaling and sterol biosynthesis | Knockout in HEK293 or HeLa cells; rescue with wild-type or mutant |
| MOCS1 | Molybdenum cofactor deficiency type A | Knockout in cell lines; complementation with MOCS1 |
| Gephyrin | Molybdenum cofactor deficiency type C | Knockout in neuronal cell lines; point mutations |
| MoaE (M. tuberculosis) | Bacterial Moco biosynthesis and pathogenesis | Knockout in M. tuberculosis; structural studies |
Molybdenum Cofactor Deficiency
Mutations in MOCS2, which encodes both subunits of the human molybdopterin synthase complex, cause molybdenum cofactor deficiency type B. This disorder is characterized by severe neurological symptoms, including intractable seizures, developmental delay, and early death. The deficiency leads to loss of activity of Moco-dependent enzymes such as sulfite oxidase, resulting in accumulation of toxic sulfite. Structural studies of the complex with precursor Z have provided insights into how disease-causing mutations impair sulfur transfer.
Cancer and Metabolic Reprogramming
Altered Moco biosynthesis has been linked to metabolic reprogramming in cancer, although direct evidence for MOCS2 in cancer is emerging. The moonlighting role of MOCS2 in alkylation damage signaling and sterol biosynthesis suggests potential connections to cancer cell survival and drug resistance. Further research is needed to establish the precise role of the molybdopterin synthase complex in cancer.
Neurodegeneration
Moco deficiency due to MOCS2 mutations leads to severe neurodegeneration, highlighting the critical role of the molybdopterin synthase complex in neuronal health. The accumulation of sulfite and other metabolites is thought to contribute to neuronal damage. Understanding the complex's function may inform therapeutic approaches for related neurodegenerative conditions.
From molybdopterin synthase complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of MOCS2 loss on Moco-dependent enzyme activity? | MOCS2 knockout cell line (e.g., HEK293) with sulfite oxidase activity assay |
| How do disease-causing mutations affect complex assembly? | Point-mutation knock-in of MOCS2 variants in human cells; co-immunoprecipitation |
| Can wild-type MOCS2 rescue the phenotype of MOCS2 knockout? | Overexpression of MOCS2A and MOCS2B in knockout cells; rescue assays |
| What are the interacting partners of the molybdopterin synthase complex? | Tagged knock-in of MOCS2B (e.g., FLAG) followed by mass spectrometry |
| How is the complex regulated by thiocarboxylation? | Knockout of MOCS3; overexpression of MOCS2A mutants |
| What is the role of moonlighting MOCS2 in alkylation damage? | Knockout of MOCS2 in cells treated with alkylating agents; viability assays |
How to Study the molybdopterin synthase complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| X-ray crystallography | Three-dimensional structure of the complex | Determining subunit arrangement and active site |
| Cryo-EM | Structure of large complexes in solution | Visualizing conformational changes |
| Enzymatic assay | Sulfur transfer activity | Measuring MPT synthase activity |
| Mass spectrometry | Thiocarboxylate formation and protein interactions | Detecting post-translational modifications |
| Co-immunoprecipitation | Protein-protein interactions | Validating subunit interactions |
| CRISPR knockout | Gene function | Creating MOCS2-null cells for phenotypic studies |
| RNA-seq | Transcriptional changes | Assessing global effects of MOCS2 loss |
| Metabolomics | Levels of Moco-related metabolites | Measuring sulfite and xanthine |
Structural Biology
X-ray crystallography and cryo-electron microscopy can resolve the structure of the molybdopterin synthase complex, revealing subunit arrangement and catalytic residues. These methods are essential for understanding how disease mutations affect complex integrity.
Biochemical Assays
Enzymatic assays measuring sulfur transfer from thiocarboxylated MoaD/MOCS2A to precursor Z can quantify complex activity. Thiocarboxylation can be monitored by mass spectrometry or radioactive labeling.
Proteomics and Interactomics
Affinity purification coupled with mass spectrometry (AP-MS) can identify interacting partners of the complex, including MOCS3 and MPTAC components. This approach helps uncover moonlighting functions.
CRISPR Screening
Genome-wide CRISPR knockout screens can identify genes that modulate sensitivity to Moco deficiency or alkylation damage, potentially revealing synthetic lethal interactions with MOCS2.
How CRISPR Can Be Used to Study GO:1990140 molybdopterin synthase complex
Knockout
CRISPR knockout of MOCS2 or MoaE can abolish molybdopterin synthase activity, leading to Moco deficiency and accumulation of precursor Z. These models are valuable for studying the metabolic consequences and for testing rescue strategies.
Point Mutation
Introducing disease-associated point mutations into MOCS2 (e.g., those found in Moco deficiency patients) via CRISPR base editing or homology-directed repair allows precise modeling of functional defects. Such models help dissect the impact of specific residues on complex assembly and catalysis.
Knock-in
Knock-in of tagged versions of MOCS2B or MOCS2A (e.g., FLAG, HA) enables affinity purification and localization studies. This approach is useful for identifying interacting partners and monitoring complex dynamics.
Overexpression
Overexpression of wild-type or mutant MOCS2 subunits can rescue knockout phenotypes or induce dominant-negative effects. This is particularly useful for structure-function studies and for testing the sufficiency of individual subunits.
How EDITGENE Supports molybdopterin synthase complex Research
Researchers studying molybdopterin synthase complex-related genes often need to determine whether a candidate gene is causally involved in Moco biosynthesis, disease pathogenesis, or moonlighting functions. Precise genetic models are essential to move from correlation to causation.
Contact EDITGENE today to design your custom CRISPR model for molybdopterin synthase complex research.
Frequently Asked Questions About molybdopterin synthase complex
What is the molybdopterin synthase complex?
It is a heterotetrameric enzyme complex that catalyzes the final sulfur-transfer step in molybdopterin biosynthesis, a key part of molybdenum cofactor (Moco) production.
What genes are involved in the molybdopterin synthase complex?
In E. coli, the genes are moaE and moaD; in humans, they are MOCS2B and MOCS2A, both encoded by the MOCS2 gene.
What is the function of GO:1990140?
GO:1990140 represents the molybdopterin synthase complex, which transfers sulfur from a sulfur carrier subunit to precursor Z to form molybdopterin.
How is the molybdopterin synthase complex regulated?
It is regulated by thiocarboxylation of the small subunit by MOCS3/MoeB, and by proteolytic processing of fusion proteins.
What diseases are associated with mutations in MOCS2?
Mutations in MOCS2 cause molybdenum cofactor deficiency type B, a severe neurological disorder.
What is the structure of the molybdopterin synthase complex?
It is a heterotetramer with two large subunits (MoaE/MOCS2B) and two small subunits (MoaD/MOCS2A).
How can CRISPR be used to study the molybdopterin synthase complex?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise dissection of subunit function and disease mechanisms.
What are the moonlighting roles of MOCS2?
MOCS2 is involved in alkylation damage signaling and sterol biosynthesis through the MPTAC complex.
What methods are used to study molybdopterin synthase complex?
Structural biology, enzymatic assays, proteomics, and CRISPR screening are commonly used.
Why is the molybdopterin synthase complex important for metabolism?
It is essential for Moco biosynthesis, which is required for sulfite oxidase, xanthine dehydrogenase, and aldehyde oxidase activities.
Conclusion
The molybdopterin synthase complex (GO:1990140) is a conserved heterotetrameric enzyme essential for molybdopterin and molybdenum cofactor biosynthesis. Its dysfunction leads to severe metabolic and neurological disorders, and its subunits have additional moonlighting roles in cellular stress responses. Advanced CRISPR models and integrated omics approaches are crucial for further dissecting its mechanism and therapeutic potential.
References
- 1. Daniels JN et al.. 2008. Crystal structure of a molybdopterin synthase-precursor Z complex: insight into its sulfur transfer mechanism and its role in molybdenum cofactor deficiency.. Biochemistry 47(2):615-26 PMID: 18092812
- 2. Wuebbens MM et al.. 2003. Mechanistic and mutational studies of Escherichia coli molybdopterin synthase clarify the final step of molybdopterin biosynthesis.. J Biol Chem 278(16):14523-32 PMID: 12571226
- 3. Suganuma T. 2022. Beyond Moco Biosynthesis-Moonlighting Roles of MoaE and MOCS2.. Molecules 27(12) PMID: 35744859
- 4. Tong Y et al.. 2005. Thermodynamic analysis of subunit interactions in Escherichia coli molybdopterin synthase.. Biochemistry 44(7):2595-601 PMID: 15709772
- 5. Yang YM et al.. 2018. Cleavage of molybdopterin synthase MoaD-MoaE linear fusion by JAMM/MPN(+) domain containing metalloprotease DR0402 from Deinococcus radiodurans.. Biochem Biophys Res Commun 502(1):48-54 PMID: 29777693
- 6. Gutzke G et al.. 2001. Thiocarboxylation of molybdopterin synthase provides evidence for the mechanism of dithiolene formation in metal-binding pterins.. J Biol Chem 276(39):36268-74 PMID: 11459846
- 7. Suganuma T et al.. 2022. MPTAC links alkylation damage signaling to sterol biosynthesis.. Redox Biol 51:102270 PMID: 35189552
- 8. Cho HJ et al.. 2025. Structural comparison of three MoaE proteins in Mycobacterium tuberculosis: Insights into molybdopterin synthase assembly and specificity.. Biochem Biophys Res Commun 768:151945 PMID: 40345009
